Back

REDOX-AHF: Restrictive versus liberal oxygenation targets in acute heart failure

9 May 2026 (13:27 - 13:36)
Organised by: Logo
Congress Presentation Part of: Hottest trials (1) Nonpharmacological Treatment HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ida Arentz Taraldsen

Copenhagen University Hospital, Copenhagen (Denmark)

9 More presentations in this session

Presentation thumbnail
SUBCUT HF II: a multicentre randomised controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart Failure
Doctor R. Campbell (Glasgow, GB)
Slides Video
Presentation thumbnail
Discussant review - SUBCUT HF II
Associate Professor J. Biegus (Wroclaw, PL)
Slides Video
Presentation thumbnail
Discussant review - REDOX-AHF
Professor M. Cikes (Zagreb, HR)
Slides Video
Presentation thumbnail
Re PHIRE – AZD3427 in heart failure with pulmonary hypertension group 2
Professor S. Rosenkranz (Cologne, DE)
Slides Video
Presentation thumbnail
Discussant review - Re-PHIRE
Professor G. Savarese (Stockholm, SE)
Slides Video

Access the full session

Session thumbnail
Hottest trials (1)
Video

The Event

Event poster

Heart Failure 2026

9 May 2026 13:27 CET
You may be interested in
thumbnail
Congress Presentation
Discussant review - REDOX-AHF
thumbnail
Congress Session
HFA Studio by ESC TV - Hot Science from Heart Failure 2026 - REDOX AHF
thumbnail
Congress Session
Hottest trials (1)

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources